Kommersiellt obunden läkemedelsinformation riktad till läkare och sjukvårdspersonal

Gentamicin

Klassificering: A

Preparat: Garamycin®, Gensumycin®, Genta-CT, Gentamicin Ebb, Gentamicin Hospira, Gentamicin Injection, USP (Pediatric), Gentamicin Sulfate In 0,9% Sodium Chloride Injection, Refobacin

ATC kod: J01GB03

Substanser: gentamicin, gentamicinsulfat

Sammanfattning

Vissa studier har visat att gentamicin-inducerad nefrotoxicitet är vanligare hos kvinnor än män, medan andra studier inte har hittat någon könsskillnad.
En stor studie har visat att gentamicin och nitrofurantoin var det mest optimala behandlingsalternativet vid urinvägsinfektion hos kvinnor och män oavsett ålder.
 
Vår bedömning är att de beskrivna skillnaderna inte motiverar olika dosering eller behandling hos kvinnor och män.

Additional information

Pharmacokinetics and dosing

Gentamicin first-dose pharmacokinetics have been studied in patients with a suspected or documented episode of Gram-negative bacterial sepsis (23 men, 9 women; mean age 68 years). Women had a larger median volume of distribution per kilogram than men (0.50 vs. 0.40 L/kg) and a lower Cmax (15.2 vs. 18.5 mg/L), even though men and women received similar weight adjusted gentamicin doses [2]. No sex differentiation in dosing has been recommended [3].

Effects

In some settings urine cultures to identify pathogens and resistance pattern cannot always be obtained and therapy of urinary tract infections then has to be empirical. A Brazilian study analyzed urine isolates to identify suitable empirical therapy options for cystitis and urinary tract infections in relation to patient’s sex and age (1098 men, 8700 women). Drug classes analyzed was ampicillin, nitrofurantoin, fluoroquinolones (ciprofloxacin and levofloxacin), trimethoprim-sulfamethoxazole, gentamicin, and ceftriazone/cefotaxime, Women exhibited higher susceptibility values for all drug classes studied than men. For women in any age group, only nitrofurantoin and gentamicin provided adequate activity for empirical therapy (> 80% susceptibility). For men in any age group, only gentamicin was suitable for empirical therapy. In women aged over 60 years, few suitable empirical treatment options were identified [1].Resistance patterns for pathogens often differ between populations. A Portuguese retrospective analysis of urinary samples (120,691 (78%) from women and 34,898 (22%) from men) gentamicin resistance was more common in male urinary samples positive for E. coli andP. mirabilis[4].

Adverse effects

Studies report contradictory results whether women are more often affected by gentamicin-induced nephrotoxicity than men or not [5]. An analysis of two randomized double-blind controlled clinical trials of aminoglycosides (121 men, 93 women) found that female sex was associated with the development of nephrotoxicity [6]. Also, a multicenter study found a higher risk of gentamicin nephrotoxicity in women [7]. However, another hospital based study found no difference between men and women in risk of developing gentamicin-induced nephrotoxicity [8].

Reproductive health issues

Regarding teratogenic aspects, please consult the Drugs and Birth Defects Database (in Swedish, Janusmed fosterpåverkan).

Försäljning på recept

Gentamicin (ATC-kod J01GB03) används huvudsakligen på sjukhus och därför saknas könsspecifika användningsdata [9].

Uppdaterat: 2019-02-26

Litteratursökningsdatum: 2016-01-08

Referenser

  1. Rocha JL, Tuon FF, Johnson JR. Sex, drugs, bugs, and age: rational selection of empirical therapy for outpatient urinary tract infection in an era of extensive antimicrobial resistance. Braz J Infect Dis. 2012;16:115-21. PubMed
  2. Gonçalves-Pereira J, Martins A, Póvoa P. Pharmacokinetics of gentamicin in critically ill patients: pilot study evaluating the first dose. Clin Microbiol Infect. 2010;16:1258-63. PubMed
  3. Gensumycin (gentamicin). Summary of Product Characteristics. Medical Products Agency Sweden; 2015.
  4. Linhares I, Raposo T, Rodrigues A, Almeida A. Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000-2009). BMC Infect Dis. 2013;13:19. PubMed
  5. Ali BH. Gentamicin nephrotoxicity in humans and animals: some recent research. Gen Pharmacol. 1995;26:1477-87. PubMed
  6. Moore RD, Smith CR, Lipsky JJ, Mellits ED, Lietman PS. Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med. 1984;100:352-7. PubMed
  7. Prince RA, Ling MH, Hepler CD, Rainville EC, Kealey GP, Donta ST et al. Factors associated with creatinine clearance changes following gentamicin therapy. Am J Hosp Pharm. 1980;37:1489-95. PubMed
  8. Sweileh WM. Gender differences in aminoglycoside induced nephrotoxicity: a prospective, hospital-based study. Curr Clin Pharmacol. 2009;4:229-32. PubMed
  9. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2015 [cited 2016-06-30.] Socialstyrelsens statistikdatabas

Författare: Linnéa Karlsson Lind, Desirée Loikas

Faktagranskat av: Mia von Euler

Godkänt av: Karin Schenck-Gustafsson